menu
    • menu

    Company profile for Stempeutics

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. It was incorporated by the Manipal Group in Jan 2006. Stempeutics strength lies in developing innovative stem cell based products by nurturing cutting edge research and clinical applications through dedicated efforts of its highly qualified team. Currently it is focusing on...
    Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. It was incorporated by the Manipal Group in Jan 2006. Stempeutics strength lies in developing innovative stem cell based products by nurturing cutting edge research and clinical applications through dedicated efforts of its highly qualified team. Currently it is focusing on the following innovative products: Company's flagship product is Stempeucel® drug.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Stempeuticsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    3rd Floor, Manipal Hospitals Whitefield #143, EPIP Industrial Area, ITPL Main...
    Telephone
    Telephone
    91 80-25028101
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.stempeutics.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/stempeutics-research-pvt--ltd-
    youtube
    YouTube
    Twitter
    Twitter
    http://www.x.com/stempeutic?s=03

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cipla Introduces Ciplostem Cell Therapy For Knee Osteoarthritis
    Cipla Introduces Ciplostem Cell Therapy For Knee Osteoarthritis

    06 Dec 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/cipla-launches-ciplostem-cell-therapy-for-knee-osteoarthritis-in-india/

    EXPRESSPHARMA
    06 Dec 2025
    Share Share
    MEDINET, Stempeutics Ink Stempeucel Option License in Japan
    MEDINET, Stempeutics Ink Stempeucel Option License in Japan

    27 Oct 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/medinet-japan-and-stempeutics-india-sign-option-licence-agreement-for-stempeucel-in-japan/

    EXPRESSPHARMA
    27 Oct 2025
    Share Share
    Phase 3 Results for Stempeutics Cell Therapy in Knee Osteoarthritis Published
    Phase 3 Results for Stempeutics Cell Therapy in Knee Osteoarthritis Published

    23 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230823353768/en

    BUSINESSWIRE
    23 Aug 2023
    Share Share
    Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis
    Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis

    19 Sep 2022

    // ECONOMIC TIMES

    https://health.economictimes.indiatimes.com/news/pharma/alkem-and-stempeutics-launch-stemone-for-treatment-of-knee-osteoarthritis/94302913

    ECONOMIC TIMES
    19 Sep 2022
    Share Share
    Stempeutics begins DCGI approved phase 3 trial for Covid-19 patients with ARDS
    Stempeutics begins DCGI approved phase 3 trial for Covid-19 patients with ARDS

    19 Jan 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145317&sid=2

    PHARMABIZ
    19 Jan 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search